235 related articles for article (PubMed ID: 32410996)
1. Paeoniflorin, a Natural Product With Multiple Targets in Liver Diseases-A Mini Review.
Ma X; Zhang W; Jiang Y; Wen J; Wei S; Zhao Y
Front Pharmacol; 2020; 11():531. PubMed ID: 32410996
[TBL] [Abstract][Full Text] [Related]
2. Paeonia lactiflora Pall. protects against ANIT-induced cholestasis by activating Nrf2 via PI3K/Akt signaling pathway.
Ma X; Zhao YL; Zhu Y; Chen Z; Wang JB; Li RY; Chen C; Wei SZ; Li JY; Liu B; Wang RL; Li YG; Wang LF; Xiao XH
Drug Des Devel Ther; 2015; 9():5061-74. PubMed ID: 26366057
[TBL] [Abstract][Full Text] [Related]
3. Paeoniflorin-free subfraction of Paeonia lactiflora Pall. shows the potential of anti-hepatic fibrosis: an integrated analysis of network pharmacology and experimental validation.
Zhang Q; Wu Y; Ge M; Xia G; Xia H; Wang L; Wei X; He H; Lin S
J Ethnopharmacol; 2022 Dec; 299():115678. PubMed ID: 36058476
[TBL] [Abstract][Full Text] [Related]
4. Paeoniflorin ameliorates cholestasis via regulating hepatic transporters and suppressing inflammation in ANIT-fed rats.
Zhao Y; He X; Ma X; Wen J; Li P; Wang J; Li R; Zhu Y; Wei S; Li H; Zhou X; Li K; Liu H; Xiao X
Biomed Pharmacother; 2017 May; 89():61-68. PubMed ID: 28214689
[TBL] [Abstract][Full Text] [Related]
5. Paeoniflorin alleviates 17α-ethinylestradiol-induced cholestasis
Wang R; Yuan T; Sun J; Yang M; Chen Y; Wang L; Wang Y; Chen W; Peng D
Front Pharmacol; 2022; 13():1064653. PubMed ID: 36479204
[TBL] [Abstract][Full Text] [Related]
6. The multifaceted mechanisms of Paeoniflorin in the treatment of tumors: State-of-the-Art.
Wang XZ; Xia L; Zhang XY; Chen Q; Li X; Mou Y; Wang T; Zhang YN
Biomed Pharmacother; 2022 May; 149():112800. PubMed ID: 35279012
[TBL] [Abstract][Full Text] [Related]
7. Paeoniflorin alleviates liver fibrosis by inhibiting HIF-1α through mTOR-dependent pathway.
Zhao Y; Ma X; Wang J; Zhu Y; Li R; Wang J; He X; Shan L; Wang R; Wang L; Li Y; Xiao X
Fitoterapia; 2014 Dec; 99():318-27. PubMed ID: 25454463
[TBL] [Abstract][Full Text] [Related]
8. Paeoniflorin protects against liver ischemia/reperfusion injury in mice via inhibiting HMGB1-TLR4 signaling pathway.
Xie T; Li K; Gong X; Jiang R; Huang W; Chen X; Tie H; Zhou Q; Wu S; Wan J; Wang B
Phytother Res; 2018 Nov; 32(11):2247-2255. PubMed ID: 30047580
[TBL] [Abstract][Full Text] [Related]
9. Paeoniflorin, the main active constituent of Paeonia lactiflora roots, attenuates bleomycin-induced pulmonary fibrosis in mice by suppressing the synthesis of type I collagen.
Ji Y; Wang T; Wei ZF; Lu GX; Jiang SD; Xia YF; Dai Y
J Ethnopharmacol; 2013 Oct; 149(3):825-32. PubMed ID: 23973787
[TBL] [Abstract][Full Text] [Related]
10. Paeoniflorin inhibition of 6-hydroxydopamine-induced apoptosis in PC12 cells via suppressing reactive oxygen species-mediated PKCδ/NF-κB pathway.
Dong H; Li R; Yu C; Xu T; Zhang X; Dong M
Neuroscience; 2015 Jan; 285():70-80. PubMed ID: 25446358
[TBL] [Abstract][Full Text] [Related]
11. DUS evaluation of nine intersubgeneric hybrids of
Xu S; Liu W; Liu X; Qin C; He L; Wang P; Kong L; Chen X; Liu Z; Ma W
Front Chem; 2023; 11():1158727. PubMed ID: 36970400
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of paeoniflorin on TNBS-induced ulcerative colitis through inhibiting NF-kappaB pathway and apoptosis in mice.
Gu P; Zhu L; Liu Y; Zhang L; Liu J; Shen H
Int Immunopharmacol; 2017 Sep; 50():152-160. PubMed ID: 28666238
[TBL] [Abstract][Full Text] [Related]
13. Paeoniflorin alleviates non-alcoholic steatohepatitis in rats: Involvement with the ROCK/NF-κB pathway.
Ma Z; Chu L; Liu H; Li J; Zhang Y; Liu W; Dai J; Yi J; Gao Y
Int Immunopharmacol; 2016 Sep; 38():377-84. PubMed ID: 27351828
[TBL] [Abstract][Full Text] [Related]
14. Paeoniflorin Protects against Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice.
Zhang L; Yang B; Yu B
Biol Pharm Bull; 2015; 38(7):1005-11. PubMed ID: 25972092
[TBL] [Abstract][Full Text] [Related]
15. Paeoniflorin: A neuroprotective monoterpenoid glycoside with promising anti-depressive properties.
Wang XL; Feng ST; Wang YT; Chen NH; Wang ZZ; Zhang Y
Phytomedicine; 2021 Sep; 90():153669. PubMed ID: 34334273
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of paeoniflorin against cobalt chloride-induced apoptosis of endothelial cells via HIF-1α pathway.
Ji Q; Yang L; Zhou J; Lin R; Zhang J; Lin Q; Wang W; Zhang K
Toxicol In Vitro; 2012 Apr; 26(3):455-61. PubMed ID: 22269387
[TBL] [Abstract][Full Text] [Related]
17. Comparative studies of paeoniflorin and albiflorin from Paeonia lactiflora on anti-inflammatory activities.
Wang QS; Gao T; Cui YL; Gao LN; Jiang HL
Pharm Biol; 2014 Sep; 52(9):1189-95. PubMed ID: 24646307
[TBL] [Abstract][Full Text] [Related]
18. Paeoniflorin regulates osteoclastogenesis and osteoblastogenesis via manipulating NF-κB signaling pathway both
Wang Y; Dai J; Zhu Y; Zhong W; Lu S; Chen H; Chai Y
Oncotarget; 2018 Jan; 9(7):7372-7388. PubMed ID: 29484117
[TBL] [Abstract][Full Text] [Related]
19. Paeonia lactiflora Pall. regulates the NF-κB-NLRP3 inflammasome pathway to alleviate cholestasis in rats.
Ma X; Wen JX; Gao SJ; He X; Li PY; Yang YX; Wei SZ; Zhao YL; Xiao XH
J Pharm Pharmacol; 2018 Dec; 70(12):1675-1687. PubMed ID: 30277564
[TBL] [Abstract][Full Text] [Related]
20. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
